Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Aug 11, 2026, 4:00 PM EDT
1.500
-0.020 (-1.32%)
After-hours: Aug 11, 2026, 6:28 PM EDT

OKYO Pharma Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-8.94-7.97-16.8-13.28-6.22
Depreciation & Amortization
00000
Stock-Based Compensation
1.60.674.581.391.78
Other Adjustments
0.081.860.060.05-0.01
Change in Receivables
0.01-0.090.440.17-0.8
Changes in Accounts Payable
0.361.222.82.96-0.3
Changes in Other Operating Activities
0.952.5-0.571.010.08
Operating Cash Flow
-5.94-1.81-9.49-7.7-5.47
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-0.01-0--0.01-0
Purchases of Investments
-6----
Investing Cash Flow
-6.01-0--0.01-0

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-0.95-2-
Net Long-Term Debt Issued (Repaid)
-0.95-2-
Issuance of Common Stock
25.021.716.217.322.15
Net Common Stock Issued (Repurchased)
25.021.716.217.322.15
Financing Cash Flow
25.022.666.219.322.15

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-0.05-0.110.06-0.28-0.87
Net Cash Flow
13.080.84-3.281.62-3.32

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-5.94-1.81-9.49-7.7-5.47
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-10.12-2.98-21.02-22.49-23.60
Levered Free Cash Flow
-7.64-0.04-14.59-7.3-5.65
Unlevered Free Cash Flow
-7.2-0.47-13.54-9.3-5.65
SEC Filings: 10-K · 10-Q